On Levodopa Interactions with Brain Disease Amyloidogenic Proteins at the Nanoscale.
Authors
Bergaglio, TaliaKummer, Nico
Bhattacharya, Shayon
Thompson, Damien
Campioni, Silvia
Nirmalraj, Peter Niraj
Issue Date
2025-04-02
Metadata
Show full item recordCitation
Bergaglio, T., Kummer, N., Bhattacharya, S., Thompson, D., Campioni, S., & Nirmalraj, P. N. (2025). On Levodopa Interactions with Brain Disease Amyloidogenic Proteins at the Nanoscale. ACS omega, 10(14), 14487–14495. https://doi.org/10.1021/acsomega.5c01028Publisher
ACSJournal
ACS omegaDOI
10.1021/acsomega.5c01028PubMed ID
40256523PubMed Central ID
PMC12004170Item Type
ArticleLanguage
enEISSN
2470-1343ae974a485f413a2113503eed53cd6c53
10.1021/acsomega.5c01028
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2025 The Authors. Published by American Chemical Society.
Related articles
- Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in α-synuclein but not in amyloid β(1-42) fibrils.
- Authors: Zhaliazka K, Kurouski D
- Issue date: 2023 Apr
- Off-pathway oligomers of α-synuclein and Aβ inhibit secondary nucleation of α-synuclein amyloid fibrils.
- Authors: Schützmann MP, Hoyer W
- Issue date: 2025 May 15
- Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins.
- Authors: Kurouski D
- Issue date: 2023 Nov 7
- Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
- Authors: Horvath I, Iashchishyn IA, Moskalenko RA, Wang C, Wärmländer SKTS, Wallin C, Gräslund A, Kovacs GG, Morozova-Roche LA
- Issue date: 2018 Jun 4
- How oxidized EGCG remodels α-synuclein fibrils into non-toxic aggregates: insights from computational simulations.
- Authors: Gonçalves PB, Palhano FL, Cordeiro Y, Sodero ACR
- Issue date: 2023 Jul 19